Elanco Animal Health Incorporated Preferred Stock, Shares Authorized
Elanco Animal Health Incorporated (ELAN) had Preferred Stock, Shares Authorized of 1.00 billion shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-05
- 2026-06-30: Preferred Stock, Shares Authorized 1.00B shares.
- 2026-03-31: Preferred Stock, Shares Authorized 1.00B shares.
- 2025-12-31: Preferred Stock, Shares Authorized 1.00B shares.
- 2024-12-31: Preferred Stock, Shares Authorized 1.00B shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2026-06-30 | 1.00B shares 10-Q · filed 2026-08-05 |
| 2026-03-31 | 1.00B shares 10-Q · filed 2026-05-06 |
| 2025-12-31 | 1.00B shares 10-Q · filed 2026-08-05 |
| 2024-12-31 | 1.00B shares 10-K · filed 2026-02-24 |
| 2023-12-31 | 1.00B shares 10-K · filed 2024-02-26 |
| 2023-03-31 | 1.00B shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 1.00B shares 10-Q · filed 2023-05-09 |
| 2022-09-30 | 1.00B shares 10-Q · filed 2022-11-08 |
| 2022-06-30 | 1.00B shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 1.00B shares 10-Q · filed 2022-05-09 |
| 2021-12-31 | 1.00B shares 10-K · filed 2023-03-01 |
| 2021-09-30 | 1.00B shares 10-Q · filed 2021-11-05 |
| 2021-06-30 | 1.00B shares 10-Q · filed 2021-08-09 |
| 2021-03-31 | 1.00B shares 10-Q · filed 2021-05-07 |
| 2020-12-31 | 1.00B shares 10-K · filed 2022-02-28 |
| 2020-09-30 | 1.00B shares 10-Q · filed 2020-11-06 |
| 2020-06-30 | 1.00B shares 10-Q · filed 2020-07-30 |
| 2020-03-31 | 1.00B shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 1.00B shares 10-K · filed 2021-03-01 |
| 2018-12-31 | 1.00B shares 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |